medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2006, Number 3

<< Back Next >>

Rev Mex Oftalmol 2006; 80 (3)

Vitrectomía más triamcinolona transoperatoria para el edema macular diabético con exudados duros

Ramírez EJA, Levine BA, Rojas JS, Celis SB, García FR, Rentería H

Language: Spanish
References: 15
Page: 112-115
PDF size: 45.46 Kb.


ABSTRACT

Objectives: To evaluate the efficacy of vitrectomy combined with intravitreal triamcinolone in patients with diabetic macular edema.
Methods: Patients with macular edema and massive hard exudates involving the fovea were included. All of them underwent a conventional vitrectomy. Two groups were developed, one with 4 mg of intravitreal triamcinolone at the end of the vitrectomy, the other as a control. Ophthalmologic exam and retinal mapping with optical coherent tomography were performed pre and postoperatively in all the patients.
Results: Triamcinolone was used in 10 patients and 5 were the control group. 60% of all the patients improved their visual acuity in one line, there was statistical difference referring to the macular thickness between the two groups at the fourth month of follow up. P: 0.04
Conclusion: Using intravitreal triamcinolone combined with vitrectomy in patients with diabetic macular edema, has not shown any advantages compared with the control group in this series.


REFERENCES

  1. Early Treatment Diabetic Retinopathy Study Research Group ETDRS. Report No. 1:Photocuagulation for diabetic macula edema. Arch Ophtalmol 1985; 103:1796-1806.

  2. Lewis H, Grow A, Blumenkrantz M, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99:753-759.

  3. Harbour J, Sniddy WE, Flynn H, Rubsamen P. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmology 1996;121:405-413.

  4. May Yang C. Surgical treatment for severe diabetic macula edema with massive hard exudates. Retina 2000; 20:121-125.

  5. Funatsu H, Yamashita H, Ikeda T y cols. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Opthalmology 2003; 135:321-326.

  6. Martidis A, Duker JS, Greenberg PB, Roger A. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109:920-927.

  7. Wilson CA, Berkowitz BA, Sato Y. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110:1155-1159.

  8. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudates age-related macular degeneration. Retina 2000; 20:244-250.

  9. Takaya K, Susuki Y, Mizutani H, Sakuraba NM. Long term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 2004; 24(1):23-29.

  10. Gandorfger A, Messmer E, Ulbig M, Kampik A. Resolution of diabetic macular edema after surgical removal of posterior hyaloid and the inner limiting membrane. Retina 2000; 20(2):126-133.

  11. Hikichi T, Fujio N, Akiba J. Association between the shortterm natural history of diabetic macula edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997; 104:473-78.

  12. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996; 122:258-260.

  13. Ikeda T, Sato K, Katano T, Hayashi Y. Vitrectomy for cystoid macular edema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophtahlmol 1999; 83:12-14.

  14. Harbour J, Smiddy W, Flynn H, Rubsamen P. Vitrectomy for diabetic macular edema associated with thickeded and taut posterior hyaloid membrane. Am J Ophtahlmol 1996; 121:405-413.

  15. Pendergast S, Hassan T, Williams G. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophtahlmol 2000; 130: 178-186.




2020     |     www.medigraphic.com